Jerusalem Venture Partners (JVP)

Jerusalem Venture Partners (JVP) stands as one of Israel's most established venture capital firms, having played a pivotal role in developing the country's technology ecosystem since 1993. Founded by Dr. Erel Margalit, JVP has deployed over $1.4 billion across multiple funds, focusing primarily on Israeli startups while maintaining a global investment perspective. The firm has built its reputation through strategic investments in cybersecurity, enterprise software, and digital health companies, sectors where Israeli entrepreneurs have demonstrated particular strength. JVP's portfolio includes notable exits such as CyberArk, which went public on NASDAQ in 2014 and achieved a market capitalization exceeding $10 billion, and Chromatis Networks, which Lucent Technologies acquired for $4.8 billion in 2000. The firm operates with a thesis that Israeli technology companies can achieve global scale by leveraging the country's military-industrial complex, particularly intelligence and security expertise. JVP has consistently raised funds every three to four years, demonstrating institutional investor confidence in their returns and market positioning. Beyond traditional venture capital activities, JVP has established innovation centers and accelerator programs, including partnerships with major corporations seeking Israeli technology solutions. The firm's investment approach spans from pre-seed rounds through growth-stage financing, though they concentrate heavily on Series A and B rounds where they can take meaningful equity stakes. JVP's geographic focus remains primarily Israeli companies, though they have expanded to include some European and U.S. investments. Their sector expertise has evolved from general technology investments in the 1990s to more focused themes around cybersecurity, fintech, and defense technology in recent years. The firm's longevity and consistent fundraising track record position them among the top-tier Israeli venture capital firms, alongside Bessemer Venture Partners Israel and Pitango Venture Capital.